Cancer Epidemiology, Prevention and Control Research
Cancer epidemiology is the study of the causes and trends of cancer, as well as the way cancer affects certain populations and geographic regions. While clinical medicine focuses on individual patients, cancer epidemiology studies large numbers of people and includes people who get cancer and those who do not.
Epidemiologists study the development of disease over long periods of time. They also study the effects of shorter-term significant exposures such as those that occur during natural or man-made disasters. Each epidemiological study can be viewed as one brick in a wall of many studies that eventually produce enough evidence to help change medical care and patient outcomes.
At the Henry Ford Cancer Institute, our cancer epidemiology, prevention and control program integrates researchers from many different disciplines of our cancer research program. We study the entire cancer continuum, including the prevention, screening, diagnosis, treatment and long-term outcomes of cancer.
Our cancer epidemiology, prevention and control research
Our research emphases include a focus on population sciences including epidemiology, health services, health promotion and cancer control.
We are the Henry Ford Health System (HFHS) seat for several multicenter national trials, including the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and the National Lung Screening Trial (NLST).
- Of the 10 PLCO trial sites, we recruited the second-largest number of subjects (more than 24,600 individuals).
- We also recruited 3,000 current or former smokers for the NLST.
- Our investigators are active in steering committee and disease group activities.
- HFHS leads the Methods and Operations Workgroup for the entire trial.
Our ongoing research includes:
- Studies with national research groups:
- Multisite HMO Cancer Research Network National Cancer Institute (NCI) study of statins and lymphoma
- Study of the association of non-steroidal anti-inflammatory drugs (NSAIDs) and polyps and epidemiological patterns of CA125 in the PLCO study population
- HMO Cancer Research Network behavioral intervention trial "Making Effective Nutritional Choices"
- The Chronic Hepatitis Cohort Study (CHeCS), a dynamic prospective, longitudinal, observational cohort study created to assess the clinical impact of chronic viral hepatitis in the United States
- Projects studying approaches to cancer prevention and treatment:
- Cancer risk reduction through lifestyle and behavioral changes
- Pharmacologic exposures that may increase or decrease cancer risk and the molecular pathways that drugs of interest may influence
- Alternative approaches including acupuncture, exercise and vitamin supplements to improve quality of life for cancer patients
- Additional studies of screening for lung, prostate, colorectal and ovarian cancers
- Removal of delays and barriers to receiving recommended medical care
- Medical informatics enhancements in contained health systems to improve disease surveillance and understand social determinants of health outcomes
- Expanded administrative data sources as a research data laboratory
- Breast cancer:
- Molecular mechanisms of breast cancer metastasis, with additional interests in the role of lymphatic invasion as a mechanism to promote regional lymph node metastasis in breast cancer
- Development of algorithms for identification of breast cancer recurrence using automated data
- Colorectal cancer:
- Electronic medical record (EMR) as a tool to encourage people to complete colorectal cancer screening
- Relationship of NSAIDs and hormone replacement therapy (HRT) use and survival among colon cancer patients
- Prostate cancer:
- Genetic and environmental prostate cancer research
- Mapping of genes that affect susceptibility to cancer
- Differences in metal exposure by race in people with prostate cancer
- Polycyclic aromatic hydrocarbons and PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a compound found in cooked meat) exposure and prostate cancer
- Molecular pathology and genetic and epigenetic epidemiology of prostate cancer
- Lung cancer:
- Screening with low-dose computed tomography
- Treatment of early stage lung cancer
- Racial and ethnic disparities:
- Quality of care and ways in which health care organizations can reduce or eliminate disparities
- Ways to improve the decision-making process in which African-American patients engage with their physicians to plan adjuvant therapy for lung, breast and colorectal cancer
- Cardiovascular disease outcomes among men diagnosed with prostate cancer and treated with androgen deprivation therapy
- Incidence and mortality of prostate and lung cancers with respect to the effects of the built and social environments
- Molecular genetic causes of racial disparities in cancer
- Skin cancer:
- Outcomes, including non-melanoma skin cancer and primary care competency in skin cancer screening
- Web-based educational interventions to improve detection of skin cancer and communicating genetic risk to patients
Support for cancer epidemiology, prevention and control
Our cancer epidemiology, prevention and control research benefits from support and funding from external and internal organizations. Find more information about our grant-funded cancer research.
Our current funding sources include:
- U.S. Food and Drug Administration (FDA) Sentinel and Observational Medical Outcomes Partnership (OMOP): This partnership supports Henry Ford Health System’s unique databases that allow us to track medication side effects and outcomes. Read more about our cancer research cores and shared resources.
- National Institutes of Health (NIH): Cancer epidemiology researchers participate in Henry Ford’s work with the NIH’s precision medicine initiative. We are one of only seven sites in the U.S. to be selected for this project. Learn more about precision medicine cancer research.
- U.S. Department of Defense
- Centers for Disease Control and Prevention
- Michigan Department of Health and Human Services
- Patient Centered Outcomes Research Institute (PCORI): PCORI is funding our study of quality of life outcomes for patients with certain head and neck cancer, and their families. Learn more about head and neck cancer research.
Our program’s supporters within Henry Ford Health System include:
- The Henry Ford Cancer Institute
- The Henry Ford Public Health Sciences department
- The Center for Health Services Research
- The Center for Health Promotion and Disease Prevention
Get involved with cancer epidemiology, prevention and control research
Cancer epidemiology, prevention and control research relies heavily on patients, researchers and physicians.
- Find a clinical trial: Henry Ford offers hundreds of clinical trials. Clinical trials help researchers study diseases and their treatment and offer eligible patients access to newly developed treatments or techniques. Learn more about clinical trials.
- Become a Henry Ford researcher: We welcome researchers at Henry Ford to contribute to our cancer epidemiology, prevention and control research work. Join our research team.
- Support cancer research: Henry Ford’s Cancer Research Advisory Group (CRAG) provides funding and resources to help advance our research. Learn how you can support cancer research
- Become a patient advisor: Henry Ford is one of only a few hospitals nationwide selected to participate in a Patient-Centered Outcomes Research study. This new approach to research empowers patients and their families to ask questions, be involved and actively participate in studies that improve quality of life for current and future patients. Learn more about patient advisors.
Many investigators involved in cancer research at Henry Ford participate in cancer epidemology, prevention and control studies. Several of our researchers focus significantly in this area. You can read more about these researchers below.
Cancer epidemiology, prevention and control research leaders
Cancer epidemiology, prevention and control clinical members
- Hammoud, Zane, M.D.
- Keller, Christian, M.D.
- Nathanson, David, M.D.
- Reickert, Craig, M.D.
- Siddiqui, Farzan, M.D.
- Simoff, Michael, M.D.
- Stone, Chad, M.D.
- Walker, Eleanor, M.D.
- Chitale, Dhananjay, M.D.
- Ghanem, Tamer, M.D., Ph.D.
Cancer epidemiology, prevention and control scientific members
- Alexander, Gwen, Ph.D.
- Cassidy-Bushrow, Andrea, Ph.D.
- Cole Johnson, Christine, Ph.D.
- Divine, George, Ph.D.
- Hanna, Rabbbie, M.D.
- Jones, Lamont, M.D.
- Kwon, David, M.D.
- Lamerato, Lois, Ph.D.
- Levin, Albert, Ph.D.
- Lu, Mei, Ph.D.
- Neslund-Dudas, Christine, Ph.D.
- Rybicki, Benjamin, Ph.D.
Publications in cancer epidemiology, prevention and control research
Henry Ford Cancer Institute researchers continually share the outcomes of their work with the scientific community through publications in scientific journals. Search below to find publications that interest you.
Publications by Henry Ford cancer epidemiology, prevention and control researchers
Bansal N, Szpiro A, Masoudi F, Greenlee RT, Smith DH, Magid DJ, Gurwitz JH, Reynolds K, Tabada GH, Sung SH, Dighe A, Cassidy-Bushrow A, Garcia-Montilla R, Hammill S, Hayes J, Kadish A, et al. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart (British Cardiac Society). 2016.
Baumer TG, Chan D, Mende V, Dischler J, Zauel R, van Holsbeeck M, Siegal DS, Divine G, Moutzouros V and Bey MJ. Effects of rotator cuff pathology and physical therapy on in vivo shoulder motion and clinical outcomes in patients with a symptomatic full-thickness rotator cuff tear. Orthopaedic journal of sports medicine. 2016; 4(9).
Bertran EA, Berlie HD, Taylor A, Divine G and Jaber LA. Diagnostic performance of HbA for diabetes in Arab vs. European populations: a systematic review and meta-analysis. Diabetic medicine: a journal of the British Diabetic Association. 2016.
Bossick AS, Peters RM, Burmeister C, Kakumanu N, Shill JE and Cassidy-Bushrow AE. Antenatal inflammation and gestational diabetes mellitus risk among pregnant African-American women. Journal of reproductive immunology. 2016; 115:1–5.
Carreno JJ, Kenney RM, Divine G, Vazquez JA and Davis SL. Randomized controlled trial to determine the efficacy of early switch from vancomycin to vancomycin alternatives as a strategy to prevent nephrotoxicity in patients with multiple risk factors for adverse renal outcomes (STOP-NT). Annals of pharmacotherapy. 2016.
Cassidy-Bushrow AE, Peters RM, Burmeister C, Bielak LF and Johnson DA. Neighborhood-level poverty at menarche and prepregnancy obesity in African-American women. Journal of pregnancy. 2016; 2016:4769121.
Cassidy-Bushrow AE, Wegienka G, Havstad S, Levin AM, Lynch SV, Ownby DR, Rundle AG, Woodcroft KJ, Zoratti EM and Johnson CC. Race-specific association of caesarean-section delivery with body size at age 2 years. Ethnicity & disease. 2016; 26(1):61–68.
Castillo J, Glezerman I, Krasa H, Lamerato L, Chiodo J, Tidwell B and Schulman K. Treatment of hyponatremia in lung cancer patients with moderate to severe hypervolemic or euvolemic hyponatremia. Chest. 2016; 150(4):694A.
Castillo JJ, Glezerman IG, Boklage SH, Chiodo J, 3rd, Tidwell BA, Lamerato LE and Schulman KL. The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients. BMC cancer. 2016; 16(1):564.
Castillo JJ, Glezerman IG, Boklage SH, Lamerato LE, Chiodo JA, Tidwell BA and Schulman KL. Incidence and prognostic importance of hyponatremia in a cohort of patients with breast cancer. Cancer Res. 2016; 76(4).
Chen KM, Datta I, Stephen JK, Chitale D, Divine G and Worsham MJ. ER negative-specific differentially methylated genes identify master regulators to expose potential epigenetic drivers of aggressive disease. Eur J Cancer. 2016; 54:S48.
Connolly MD, Zervos MJ, Barone CJ, 2nd, Johnson CC and Joseph CL. The mental health of transgender youth: Advances in understanding. Journal of adolescent health: official publication of the Society for Adolescent Medicine. 2016.
Crawford EL, Levin A, Safi F, Lu M, Baugh A, Zhang X, Yeo J, Khuder SA, Boulos AM, Nana-Sinkam P, Massion PP, Arenberg DA, Midthun D, Mazzone PJ, Nathan SD, Wainz R, et al. Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. BMC pulmonary medicine. 2016; 16(1):16.
Demos D, Divine G, Paone G, Borgi J, Morgan J, Allenspach L, Stagner L and Nemeh H. Abo compatibility in lung transplantation. J Heart Lung Transplant. 2016; 35(4):S368.
Elibe E, Boyce-Fappiano D, Walker EM, Lee IY, Rock J, Siddiqui S and Siddiqui F. Significance of hormone therapy and bisphosphonate use on vertebral compression fracture (vcf) incidence following spine stereotactic body radiation therapy (sbrt) for breast cancer metastases. International journal of radiation oncology, biology, physics. 2016; 96(2s):E509.
Farhan SY, Divine G, Neme K, Pelland D, Wautelet S, Mikulandric N, Ruemenapp K, Peres E and Janakiraman N. Cytomegalovirus and effect on early chimerism in patients with myeloid disorders undergoing stem cell transplantation using reduced toxicity ablative conditioning regimen. Blood. 2015; 126(23):3.
Feldman AM, Zhang Z, Buekers T and Elshaikh MA. Management of gynaecologic plasmacytoma: A review article. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2016:1–6.
Feng M, Moran JM, Benedetti L, Boike TP, Dryden D, Fraser C, Griffith KA, Gustafson GS, Haywood J, Jagsi R, Matuszak MM, Nurushev TS, Radawski JD, Speers C, Walker EM, Hayman JA, et al. Time trends and predictors of heart dose from breast radiation therapy in a large consortium of community and academic practices. International journal of radiation oncology, biology, physics. 2016; 96(2s):E15–E16.
Foster MA, Xing J, Moorman AC, Boscarino J, Gordon SC, Lu M, Rupp L, Schmidt MA, Trinacty CM, Xu F, Holmberg SD and Spradling PR. Frequency of and factors associated with receipt of liver-related specialty care among patients with hepatitis c in the chronic hepatitis cohort study. Digestive diseases and sciences. 2016.
Frendl D, Epstein M, Fouayzi H, Krajenta R, Rybicki B and Sokoloff M. Impact of guidelines on prostate cancer screening in a population-based setting, 2000–2014: Preliminary results from the first AUA data grant. The Journal of urology. 2016; 195(4):e543.
Fu AZ, Tsai HT, Haque R, Ulcickas Yood M, Cassidy-Bushrow AE, Van Den Eeden SK, Keating NL, Smith MR, Zhou Y, Aaronson DS and Potosky AL. Mortality and androgen-deprivation therapy as salvage treatment for biochemical recurrence after primary therapy for clinically localized prostate cancer. Journal of urology. 2016.
Fu AZ, Tsai HT, Haque R, Ulcickas Yood M, Van Den Eeden SK, Cassidy-Bushrow AE, Zhou Y, Keating NL, Smith MR, Aaronson DS and Potosky AL. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World journal of urology. 2016.
Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, Panzer AR, LaMere B, Rackaityte E, Lukacs NW, Wegienka G, Boushey HA, Ownby DR, Zoratti EM, Levin AM, Johnson CC, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nature medicine. 2016.
Garcia-Rodriguez L, Jones L, Chen KM, Datta I, Divine G and Worsham MJ. Causal network analysis of head and neck keloid tissue identifies potential master regulators. Laryngoscope. 2016.
Gardner AK, Nepomnayshy D, Reickert C, Gee DW, Brydges R, Korndorffer JR, Jr., Scott DJ and Sachdeva AK. The value proposition of simulation. Surgery. 2016.
Ghanem AI, Khan N, Mahan M, Buekers T and Elshaikh MA. Survival endpoints with or without lymphadenectomy in women with stage I endometrial carcinoma: A matched-pair analysis. J Clin Oncol. 2016; 34.
Greenlee H, Neugut AI, Falci L, Hillyer GC, Buono D, Mandelblatt JS, Roh JM, Ergas IJ, Kwan ML, Lee M, Tsai WY, Shi Z, Lamerato L, Kushi LH and Hershman DL. Association between complementary and alternative medicine use and breast cancer chemotherapy initiation: The breast cancer quality of care (bqual) study. JAMA oncology. 2016.
Greenlee H, Neugut AI, Falci L, Hillyer GC, Buono D, Roh JM, Ergas IJ, Kwan ML, Lee M, Tsai WY, Shi Z, Lamerato L, Mandelblatt JS, Kushi LH and Hershman DL. Complementary and alternative medicine use and breast cancer chemotherapy initiation: The BQUAL study. Cancer Research. 2016; 76(4).
Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Zheng W, Pettaway CA, Yeboah ED, Tettey Y, et al. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nature communications. 2016; 7:10979.
Haley L, Buekers TE, Burmeister C and Elshaikh MA. Older age is no longer an adverse prognostic factor in women with early-stage endometrial carcinoma: A matched analysis. Gynecol Oncol. 2016; 141:70–71.
Han Y, Rand KA, Hazelett DJ, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Schumacher FR, Berndt SI, Wang Z, Xu J, Rohland N, et al. Prostate cancer susceptibility in men of African ancestry at 8q24. Journal of the National Cancer Institute. 2016; 108(7).
Haque R, Xu XQ, Yood MU, Cassidy-Bushrow AE, Van den Eeden SK and Potosky AL. Cardiovascular disease risk and androgen deprivation therapy in patients with localized prostate cancer. Pharmacoepidemiol Drug Saf. 2015; 24:323–324.
Healy MA, McCahill LE, Chung M, Berri R, Ito H, Obi SH, Wong SL, Hendren S and Kwon D. Intraoperative fluid resuscitation strategies in pancreatectomy: Results from 38 hospitals in michigan. Annals of surgical oncology. 2016.
Hershman DL, Kushi LH, Hillyer GC, Coromilas E, Buono D, Lamerato L, Bovbjerg DH, Mandelblatt JS, Tsai WY, Zhong X, Jacobson JS, Wright JD and Neugut AI. Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL). Breast cancer research and treatment. 2016.
Hijaz M, Chhina J, Mert I, Taylor M, Dar S, Al-Wahab Z, Ali-Fehmi R, Buekers T, Munkarah AR and Rattan R. Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer. Gynecol Oncol. 2016.
Hung J, Taylor AR, Divine GW, Hafron JM and Hwang C. The effect of time to castration resistance on outcomes with abiraterone and enzalutamide in metastatic prostate cancer. Clinical genitourinary cancer. 2016.
Jagsi R, Griffith KA, Moran JM, Matuszak MM, Feng M, Marsh R, Boike TP, Grills IS, Gustafson GS, Heimburger DK, Nurushev TS, Radawski JD, Walker EM, Hayman JA and Pierce LJ. Comparative effectiveness analysis of 3DCRT versus intensity modulated radiation therapy in a prospective multicenter cohort of breast cancer patients. International journal of radiation oncology, biology, physics. 2016; 96(2s):S207.
Johnson CC and Ownby DR. Allergies and asthma: Do atopic disorders result from inadequate immune homeostasis arising from infant gut dysbiosis? Expert review of clinical immunology. 2016.
Johnson CC and Ownby DR. The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases. Translational research: the journal of laboratory and clinical medicine. 2016.
Jones LR, Greene J, Chen KM, Divine G, Chitale D, Shah V, Datta I and Worsham MJ. Biological significance of genome-wide DNA methylation profiles in keloids. Laryngoscope. 2016.
Joseph CL, Zoratti EM, Ownby DR, Havstad S, Nicholas C, Nageotte C, Misiak R, Enberg R, Ezell J and Johnson CC. Exploring racial differences in IgE-mediated food allergy in the WHEALS birth cohort. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2016.
Joseph CLM, Ownby DR, Zoratti E, Johnson D, Considine S, Bourgeois R, Melkonian C, Miree C, Cole Johnson C and Lu M. Recruitment experience for a pragmatic randomized controlled trial: Using EMR initiatives and minimizing research infrastructure. Clin Res Regul Aff. 2016:1–8.
Kabbani L, Balraj P, Mathews J, Tinney F, Jr., Schwartz S, Kwon D, Braun F and Wasilenko S. Epithelioid hemangioendothelioma presenting as inferior vena cava obstruction diagnosed using an endovascular thrombectomy device. Annals of vascular surgery. 2016.
Kaljee LM, Kilgore P, Prentiss T, Lamerato L, Moreno D, Arshad S and Zervos M. 'You need to be an advocate for yourself': Factors associated with decision-making regarding influenza and pneumococcal vaccine use among U.S. older adults from within a large metropolitan health system. Human vaccines & immunotherapeutics. 2016:0.
Kessler MD, Yerges-Armstrong L, Taub MA, Shetty AC, Maloney K, Jeng LJ, Ruczinski I, Levin AM, Williams LK, Beaty TH, Mathias RA, Barnes KC and O'Connor TD. Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry. Nature communications. 2016; 7:12521.
King D, Silverstein JM, Munir KM, Roe ED, Fox JL, Kouznetsova M and Lamerato LE. Capturing acromegaly diagnosis and treatment across four major hospital systems: Insights from the acromedic (acromegaly multi-site electronic data innovative consortium) database. Endocrine Reviews. 2016; 37(2).
Levin AM, Sitarik AR, Havstad SL, Fujimura KE, Wegienka G, Cassidy-Bushrow AE, Kim H, Zoratti EM, Lukacs NW, Boushey HA, Ownby DR, Lynch SV and Johnson CC. Joint effects of pregnancy, sociocultural, and environmental factors on early life gut microbiome structure and diversity. Scientific reports. 2016; 6:31775.
Li C, Zhang Y, Levin AM, Chopp M and Zhang ZG. Characterization of micrornas and their target proteins in distal axons of cortical neurons. Stroke. 2016; 47.
Li J, Gordon S, Rupp L, Zhang T, Boscarino J, Trinacty C, Schmidt M, Moorman A, Holmberg S and Lu M. Long-term fibrosis and viral level progression among treated and untreated patients with chronic hepatitis B. J Hepatol. 2016; 64(2):S371.
Li J, Gordon SC, Rupp LB, Zhang T, Trudeau S, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Boscarino JA, Daida YG, Schmidt MA and Lu M. Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B. Journal of gastroenterology and hepatology. 2016.
Lindquist KJ, Paris PL, Hoffmann TJ, Cardin NJ, Kazma R, Mefford JA, Simko JP, Ngo V, Chen Y, Levin AM, Chitale D, Helfand BT, Catalona WJ, Rybicki BA and Witte JS. Mutational landscape of aggressive prostate tumors in African American men. Cancer Res. 2016.
Liu XS, Fan BY, Pan WL, Li C, Levin AM, Wang X, Zhang RL, Zervos TM, Hu J, Zhang XM, Chopp M and Zhang ZG. Identification of miRNomes associated with adult neurogenesis after stroke using Argonaute 2-based RNA sequencing. RNA biology. 2016:0.
Lu M, Gordon SC, Li J, Rupp LB, Zhou Y, Moorman AC, Spradling P, Teshale EH, Boscarino JA, Daida Y, Schmidt MA, Trudeau S and Holmberg SD. Hepatitis C complications: Prevalence and disparities in a large US cohort 2006–2014. Hepatology. 2016; 63(1):95A–96A.
Lu M, Li J, Rupp LB, Boscarino JA, Raebel M, Schmidt MA, Haller IV, Daida Y, Rodriguez CV, Sahota A, VanWormer JJ, Romanelli RG, Vincent J and Gordon SC. Prevalence of primary biliary cholangitis (PBC) in large US health care systems: Case ascertainment using electronic health records. Hepatology. 2016; 63(1):196A.
Lu M, Li J, Rupp LB, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Zhou Y, Boscarino JA, Schmidt MA, Lamerato LE, Trinacty C, Trudeau S and Gordon SC. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma. Journal of viral hepatitis. 2016.
Lu M, Li J, Zhang T, Rupp LB, Trudeau S, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Xu F, Boscarino JA, Schmidt MA, Vijayadeva V and Gordon SC. Long-term reduction in liver fibrosis, based on serum biomarkers, in patients with sustained viral responses to HCV treatment. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2016.
Luria CJ, Sitarik AR, Havstad S, Wegienka GR, Kim H, Zoratti EM, Joseph CLM and Cassidy-Bushrow AE. Association between asthma symptom scores and increased perceived stress and trait anxiety in asthmatic adolescents. J Allergy Clin Immunol. 2016; 137(2):AB11.
Mark DB, Federspiel JJ, Cowper PA, Anstrom KJ, Hoffmann U, Patel MR, Davidson-Ray L, Daniels MR, Cooper LS, Knight JD, Lee KL, Douglas PS, Bonow R, Anderson G, Bertoni A, Carr JJ, et al. Economic outcomes with anatomical versus functional diagnostic testing for coronary artery disease. Ann Intern Med. 2016; 165(2):94–102.
Mathias RA, Taub MA, Gignoux CR, Fu W, Musharoff S, O'Connor TD, Vergara C, Torgerson DG, Pino-Yanes M, Shringarpure SS, Huang L, Rafaels N, Boorgula MP, Johnston HR, Ortega VE, Levin AM, et al. A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome. Nature communications. 2016; 7:12522.
Monaghan KG, Gonzalez HC, Levin AM, Abouljoud MS and Gordon SC. Post-transplant course of hepatitis C after living donor liver transplantation in association with polymorphisms near IFNL3. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 2015; 35(4):313–316.
Moonka D, Nagai S, Divine G and Salgia R. Influence of donor age and cold ischemia on recurrence of hepatocellular carcinoma after liver transplantation. Transplantation. 2016; 100(7):S427.
Moonka D, Nagai S, Gadde R, Datta L, Divine G, Abouljoud MS and Salgia R. Effect of tumor necrosis from loco-regional therapy prior to liver transplantation on hepatocellular carcinoma recurrence after transplant. Hepatology. 2016; 63(1):640A–641A.
Moonka D, Shah V, Datta L, Gadde R, Divine G, Yoshida A, Jafri SM and Salgia R. Degree of tumor necrosis from pre-transplant loco-regional therapy is associated with tumor free survival after liver transplantation. Transplantation. 2016; 100(7):S429.
Moorman AC, Tong X, Spradling PR, Rupp LB, Gordon SC, Lu M, Teshale EH, Boscarino JA, Trinacty CM, Schmidt MA, Xu F and Holmberg SD. Prevalence of renal impairment and associated conditions among hcv-infected persons in the chronic hepatitis cohort study (CHeCS). Digestive diseases and sciences. 2016.
Morris D, Chopp M, Cheung WL, Cui Y, Zhang T, Lu M, Zhang L and Zhang ZG. Thymosin β4 for the treatment of sub-acute stroke in aged rats. Stroke. 2016; 47.
Munkarah AR, Kim S, Buekers TE, Chhina J, Poisson L, Giri S and Rattan R. Metabolic effects of metformin treatment in ovarian cancer cell lines. Gynecol Oncol. 2016; 141:168.
Nazem-Zadeh MR, Elisevich K, Air EL, Schwalb JM, Divine G, Kaur M, Wasade VS, Mahmoudi F, Shokri S, Bagher-Ebadian H and Soltanian-Zadeh H. DTI-based response-driven modeling of mTLE laterality. NeuroImage Clinical. 2016; 11:694–706.
Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Buono DL, Nathanson SD, Bovbjerg DH, Mandelblatt JS, Tsai WY, Jacobson JS and Hershman DL. A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL). Breast cancer research and treatment. 2016.
Ownby D and Johnson CC. Recent understandings of pet allergies. F1000Research. 2016; 5.
Ownby DR and Johnson CC. Dogs, cats and asthma: Will we ever really know the true risks and benefits? J Allergy Clin Immunol. 2016.
Petersen S, Rubinfeld I, Buekers T and Sangha R. Analysis of risk factors for urologic injuries after minimally invasive vs abdominal hysterectomy. J Minim Invasive Gynecol. 2016; 23(7):S29.
Petrie JG, Ohmit SE, Cheng CK, Martin ET, Malosh RE, Lauring AS, Lamerato LE, Reyes KC, Flannery B, Ferdinands JM and Monto AS. Influenza vaccine effectiveness against antigenically drifted influenza higher than expected in hospitalized adults: 2014–2015. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2016.
Pongracic JA, Krouse RZ, Babineau DC, Zoratti EM, Cohen RT, Wood RA, Khurana Hershey GK, Kercsmar CM, Gruchalla RS, Kattan M, Teach SJ, Johnson CC, Bacharier LB, Gern JE, Sigelman SM, Gergen PJ, et al. Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents. J Allergy Clin Immunol. 2016; 138(4):1030–1041.
Qiu S, Divine GW, Palnitkar S, Kulkarni P, Guthrie TS, Honasoge M and Rao SD. Bone structure and turnover status in postmenopausal women with atypical femur fracture after prolonged bisphosphonate therapy. Calcified tissue international. 2016.
Rand KA, Song C, Dean E, Serie DJ, Curtin K, Sheng X, Hu D, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailwadhi S, Singhal S, Pawlish KS, Peters ES, CH BL, Stram A, et al. A meta-analysis of multiple myeloma risk regions in African and European ancestry populations identifies putatively functional loci. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016.
Reynolds K, Go AS, Leong TK, Boudreau DM, Cassidy-Bushrow AE, Fortmann SP, Goldberg RJ, Gurwitz JH, Magid DJ, Margolis KL, McNeal CJ, Newton KM, Novotny R, Quesenberry CP, Jr., Rosamond WD, Smith DH, et al. Trends in incidence of hospitalized acute myocardial infarction in the cardiovascular research network (CVRN). The American journal of medicine. 2016.
Rybicki BA, Rundle A, Kryvenko ON, Mitrache N, Do KC, Jankowski M, Chitale DA, Trudeau S, Belinsky SA and Tang D. Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer. International journal of cancer Journal international du cancer. 2016.
Schulman KL, Lamerato LE, Dalal MR, Sung J, Jhaveri M, Koren A, Mallya UG and Foody JM. Development and validation of algorithms to identify statin intolerance in a US administrative database. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2016; 19(6):852–860.
Schwartz AG, Lusk CM, Wenzlaff AS, Watza D, Pandolfi S, Mantha L, Cote ML, Soubani AO, Walworth G, Wozniak A, Neslund-Dudas C, Ardisana AA, Flynn MJ, Song T, Spizarny DL, Kvale PA, et al. Risk of lung cancer associated with COPD phenotype based on quantitative image analysis. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016; 25(9):1341–1347.
Simmons RM, Ballman KV, Cox C, Carp N, Sabol J, Hwang RF, Attai D, Sabel M, Nathanson D, Kenler A, Gold L, Kaufman C, Han L, Bleznak A, Stanley Smith J, Holmes D, et al. A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: Results from ACOSOG (Alliance) Z1072. Annals of surgical oncology. 2016.
Sleder A, Tackett S, Cerasale M, Mittal C, Isseh I, Radjef R, Taylor A, Farha R, Lupak O, Larkin D, Lamerato L, Divine G, Wisdom K, Baker-Genaw K and O'Neill W. Socioeconomic and racial disparities: A case-control study of patients receiving transcatheter aortic valve replacement for severe aortic stenosis. Journal of racial and ethnic health disparities. 2016.
Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Lu M, Teshale EH, Boscarino JA, Daida Y, Schmidt MA and Holmberg SD. Preliminary clinical outcome data among patients with hepatitis C virus infection receiving direct-acting antiviral therapy in the Chronic Hepatitis Cohort Study, 2014–2015. Hepatology. 2016; 63(1):487A–488A.
Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Lu M, Teshale EH, Boscarino JA, Daida Y, Schmidt MA and Holmberg SD. Uptake of and factors associated with direct-acting antiviral therapy among patients infected with hepatitis C virus in the chronic hepatitis cohort study, 2014–2015. Hepatology. 2016; 63(1):10A–11A.
Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Teshale ET, Lu M, Boscarino JA, Schmidt MA, Trinacty CM and Holmberg SD. Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006–2013. Alimentary pharmacology & therapeutics. 2016.
Teshale EH, Xing J, Moorman A, Holmberg SD, Spradling PR, Gordon SC, Rupp LB, Lu M, Boscarino JA, Trinacity CM, Schmidt MA and Xu F. Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006–2013. Journal of viral hepatitis. 2016.
Teshale EH, Zhong Y, Moorman AC, Spradling PR, Holmberg SD, Rupp LB, Lu M, Gordon SC, Boscarino JA, Daida Y and Schmidt MA. Alcohol use disorder among chronic hepatitis C patients: Prevalence and treatment outcome, CHeCS, 2006–2013. Hepatology. 2016; 63(1):873A–874A.
Vance S, Al Feghali KA, Taylor A, Kaur M, Neslund-Dudas C, Chetty IJ, Simoff M, Ajlouni M and Movsas B. Do race and income influence quality of life (QOL) or survival outcomes after lung stereotactic body radiation therapy (SBRT)? a prospective study. International journal of radiation oncology, biology, physics. 2016; 96(2s):E534.
Vance S, Burmeister C, Rasool N, Buekers T and Elshaikh MA. Salvage versus adjuvant radiation treatment for women with early-stage endometrial carcinoma: A matched analysis. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society. 2016; 26(2):307–312.
Wang DD, Eng M, Greenbaum A, Myers E, Forbes M, Pantelic M, Song T, Nelson C, Divine G, Taylor A, Wyman J, Guerrero M, Lederman RJ, Paone G and O'Neill W. Predicting LVOT obstruction after TMVR. JACC Cardiovascular imaging. 2016.
Wang L, Chopp M, Szalad A, Lu X, Jia L, Lu M, Zhang RL and Zhang ZG. Tadalafil promotes the recovery of peripheral neuropathy in type II diabetic mice. PloS one. 2016; 11(7):e0159665.
Wegienka G, Havstad S, Kim H, Zoratti E, Ownby D, Woodcroft KJ and Johnson CC. Subgroup differences in the associations between dog exposure during the first year of life and early life allergic outcomes. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2016.
Wegienka G, Kaur H, Sangha R and Cassidy-Bushrow AE. Maternal-cord blood vitamin d correlations vary by maternal levels. Journal of pregnancy. 2016; 2016:7474192.
Worsham MJ, Chen KM, Chitale D, Stephen JK and Divine G. Differentially methylated miRNA methylomes of normal breast tissue from ER negative and ER positive breast cancer mimic their respective tumor phenotypes. Can Res. 2016; 76(4).
Worsham MJ, Chen KM, Datta I, Stephen JK, Chitale D and Divine G. Epigenetically altered microRNA mediated pathway dysregulation in ER negative breast cancer. Can Res. 2016; 76(4).
Worsham MJ, Chen KM, Datta I, Stephen JK, Chitale D, Gothard A and Divine G. The biological significance of methylome differences in human papilloma virus associated head and neck cancer. Oncology Letters. 2016; 12(6):4949–4956.
Worsham MJ, Chen KM, Stephen JK, Datta I and Divine G. Integrating epigenetics into personalized medicine. Eur J Cancer. 2016; 54:S44.
Xu F, Moorman AC, Tong X, Gordon SC, Rupp LB, Lu M, Teshale EH, Spradling PR, Boscarino JA, Trinacty CM, Schmidt MA and Holmberg SD. All-cause mortality and progression risks to hepatic decompensation and hepatocellular carcinoma in patients infected with hepatitis c virus. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2016; 62(3):289–297.
Yadav P, Eng M, Divine G, Wang DD, Arjomand-Fard H, Wyman J, Isley M, Borgi J, Paone G, Greenbaum A and O'Neill W. Outcomes of impella assisted percutaneous balloon aortic valvuloplasty in very high risk severe aortic stenosis patients. J Am Coll Cardiol. 2016; 67(13):404.
Yan T, Venkat P, Chopp M, Zacharek A, Ning R, Roberts C, Zhang Y, Lu M and Chen J. Neurorestorative responses to delayed human mesenchymal stromal cells treatment of stroke in type 2 diabetic rats. Stroke. 2016; 47(11):2850–2858.
Yessayan L, Moore C, Lu M and Yee J. Bone-specific alkaline phosphatase and bone turnover in African American hemodialysis patients. Hemodialysis international International Symposium on Home Hemodialysis. 2016.
Zhang J, Zhang ZG, Li Y, Lu M, Zhang Y, Elias SB and Chopp M. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system. Neurobiology of disease. 2016; 88:85–95.
Zhang L, Chopp M, Lu M, Zhang T, Winter S, Doppler E, Meier D, Chao L, Eapen A, Pabla P and Gang Zhang Z. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study. International journal of stroke: official journal of the International Stroke Society. 2016.
Zhang L, Chopp M, Zhang Y, Xiong Y, Li C, Sadry N, Rhaleb I, Lu M and Zhang ZG. Diabetes mellitus impairs cognitive function in middle-aged rats and neurological recovery in middle-aged rats after stroke. Stroke. 2016; 47(8):2112–2118.
Zhang X, Crawford EL, Blomquist TM, Khuder SA, Yeo J, Levin AM and Willey JC. Haplotype and diplotype analyses of variation in ERCC5 transcription cis-regulation in normal bronchial epithelial cells. Physiological genomics. 2016; 48(7):537–543.
Zhou K, Yee SW, Seiser EL, van Leeuwen N, Tavendale R, Bennett AJ, Groves CJ, Coleman RL, van der Heijden AA, Beulens JW, de Keyser CE, Zaharenko L, Rotroff DM, Out M, Jablonski KA, Chen L, et al. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nature genetics. 2016.